Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data
American Journal of Hypertension · 2026
DOI: 10.1093/ajh/hpaf232 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Yun Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated LiHuili Hospital of Ningbo University, Ningbo, Zhijiang, China. Hauptthemen laut MEDLINE: Heart Failure, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Zhejiang Provincial Medical and Health Science and Technology Project, Zhejiang Provincial Medical Association Clinical Research Fund.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Hypertensive heart disease is a major cause of heart failure (HF); this study evaluates the global burden and trends of HF attributable to hypertensive heart disease from 1990 to 2021.
Methods
We collected detailed information on prevalence, years lived with disability of HF attributable to hypertensive heart disease from the Global Burden of Disease study 2021 across 204 countries and territories. Numbers, age-standardized rates, and average annual percent change of HF attributable to hypertensive heart disease prevalence and years lived with disability were compared by age, sex, and socio-demographic index.
Results
In 1990 and 2021, hypertensive heart disease-related HF affected more than 4.6 million and 13 million individuals globally, demonstrating an age-standardized prevalence rate of 125.4 [95% uncertainty interval (UI), 99.0 to 158.0] and 148.3 per 100,000 (95% UI, 117.3-186.3) and an age-standardized years lived with disability rate of 11.2 (95% UI, 7.2-15.7) and 13.2 (95% UI, 8.4-19.1) per 100,000, respectively. Notably, from 1990 to 2021, the global age-standardized prevalence and years lived with disability rates increased consistently, with an average annual percent change of 0.53 (95% CI, 0.52-0.54) and 0.54 (95% CI, 0.53-0.55), respectively.
Conclusions
The global burden of HF attributable to hypertensive heart disease has risen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated LiHuili Hospital of Ningbo University, Ningbo, Zhijiang, China.
ORCID-Profile: Yun Huang
Förderung
- Zhejiang Provincial Medical and Health Science and Technology Project
- Zhejiang Provincial Medical Association Clinical Research Fund
Zitieren
APA
Huang, Y., Ma, L., Zhang, Y., Rong, W., Zhang, R., Fang, C., Wang, R., & Zhou, H. (2026). Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf232
Vancouver
Huang Y, Ma L, Zhang Y, Rong W, Zhang R, Fang C, et al. Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf232
BibTeX
@article{Huang2026,
author = {Huang, Yun and Ma, Lili and Zhang, Yuyu and Rong, Weibo and Zhang, Ronghui and Fang, Chongbo and Wang, Rixiang and Zhou, Hua},
title = {Global burden of heart failure attributable to hypertensive heart disease: a 30-year population-based analysis using Global Burden of Disease 2021 data},
journal = {American Journal of Hypertension},
year = {2026},
doi = {10.1093/ajh/hpaf232}
}
EUVIMED